University of Sussex
Browse

File(s) under permanent embargo

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

journal contribution
posted on 2023-06-08, 18:31 authored by F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F André, C H Barrios, J Bergh, L Biganzoli, K L Blackwell, M J Cardoso, T Cufer, N El Saghir, Lesley FallowfieldLesley Fallowfield, D Fenech, P Francis, K Gelmon, S H Giordano, J Gligorov, A Goldhirsch, N Harbeck, N Houssami, C Hudis, B Kaufman, I Krop, S Kyriakides, U N Lin, M Mayer, S D Merjaver, E B Nordstrom, O Pagani, A Partridge, F Penault-Llorca, M J Piccart, H Rugo, G Sledge, C Thomssen, L Van't Veer, D Vorobiof, C Vrieling, N West, B Xu, E Winer
Advanced Breast Cancer (ABC) is a treatable but still generally incurable disease. The goals of care are to optimize both length and quality of life. Due to continuous research, several advances have been made, particularly for the HER-2-positive and for Luminal-like subtypes. Notwithstanding these advances, median overall survival of patients with ABC is still only 2–3 years, although the range is wide [1–5], and survival may be longer for patients treated in specialized institutions [6]. Implementation of current knowledge is highly variable among countries and within each country.

History

Publication status

  • Published

File Version

  • Published version

Journal

The Breast

ISSN

0960-9776

Publisher

Elsevier

Issue

5

Volume

23

Page range

489-502

Department affiliated with

  • Sussex Health Outcomes Research & Education in Cancer (SHORE-C) Publications

Full text available

  • No

Peer reviewed?

  • Yes

Legacy Posted Date

2014-09-26

First Compliant Deposit (FCD) Date

2014-09-26

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC